The study also recaptured 14 significant variants in known IBD causal candidates, including variants in CARD9, IL23R, and NOD2. The remaining 20 variants either tagged known causal variants through linkage disequilibrium or had very small posterior inclusion probabilities (PIP) from fine-mapping, making them highly unlikely to be causal for CD. Here, IL23R is linked to inflammatory bowel disease.